Home Newsfeeds Compass Point Downgrades Argo Blockchain to Neutral

Compass Point Downgrades Argo Blockchain to Neutral

Compass Point analyst Chase White downgrades Argo Blockchain (NASDAQ:ARBK) from Buy to Neutral.

byBenzinga Newsdesk

October 25, 2022

1 minute read

Compass Point analyst Chase White downgrades Argo Blockchain (NASDAQ:ARBK) from Buy to Neutral.

Xponential Fitness Q4 EPS $0.11 Beats $0.10 Estimate, Sales $71.27M Beat $66.74M Estimate

By Bill Haddad

March 2, 5:22 PM

Xponential Fitness (NYSE:XPOF) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.10 by 10 percent. This is a 152.38 percent increase over losses of $(0.21) per share from the

XPOF

United Nations High Commissioner For Refugees Awards Polar Power Initial Contract To Assure Uninterrupted Quality Electric Power For African Offices

By Benzinga Newsdesk

December 20, 9:17 AM

Pilot program designed to showcase the provision of reliable, easily maintained, and cost-effective electric power in bad or no grid locationsGARDENA, CA, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Polar Power, Inc. ("Polar

POLA

News

Earlier Bloomberg Reported Enbridge Rations Canada Pipeline Space, Adding to Oil Headwinds

By Charles Gross

November 21, 3:05 PM

https://www.bloomberg.com/news/articles/2022-11-21/enbridge-rations-canada-pipeline-space-adding-to-oil-headwinds

ENB

AstraZeneca/Daiichi’s Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor

By Vandana Singh

April 8, 10:34 AM

FDA approves Daiichi Sankyo's and AstraZeneca's Enhertu for unresectable or metastatic HER2+ solid tumors. Accelerated approval based on ORR and DOR. Boxed warnings for ILD/pneumonitis and embryo-fetal toxicity. ENHERTU's efficacy demonstrated in DESTINY trials.

AZN

Compass Point Downgrades Argo Blockchain to Neutral

Related Posts

Xponential Fitness Q4 EPS $0.11 Beats $0.10 Estimate, Sales $71.27M Beat $66.74M Estimate

United Nations High Commissioner For Refugees Awards Polar Power Initial Contract To Assure Uninterrupted Quality Electric Power For African Offices

Earlier Bloomberg Reported Enbridge Rations Canada Pipeline Space, Adding to Oil Headwinds

AstraZeneca/Daiichi’s Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor